Method for rapidly detecting 15 prostaglandin analogues in cosmetics and application thereof
Through ultra-high performance liquid chromatography-quadrupole-time-flight high-resolution mass spectrometry technology, a rapid detection method for 15 prostaglandin analogs in cosmetics was established, which solved the problem of incomplete detection in the existing technology and realized the market Rapid screening and determination of widely used prostaglandin analogs provides more comprehensive and effective cosmetic quality supervision support.
Patent Information
- Application Number
- CN202411103507.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-13
- Publication Date
- 2024-11-22
AI Technical Summary
The prior art is difficult to quickly screen and detect 15 prostaglandin analogs in cosmetics, especially in the absence of standards, and the traditional methods are only suitable for the analysis of known compounds, and cannot fully cover the wide range of prostaglandin similarities used on the market. Things.
Utilizing ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry (UPLC-Q-TOF MS) technology, rapid screening and determination of 15 prostaglandin analogs is achieved through the establishment of databases and preparation of standard solutions. Qualitative and quantitative analysis of compounds including latanolide benzoate.
It realizes rapid, simple and accurate detection of 15 prostaglandin analogs in cosmetics, provides more comprehensive and effective technical support for cosmetic quality supervision, improves analysis speed and sensitivity, and ensures the accuracy of the test results.
Smart Images

Figure CN119000922A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of analysis and detection, and in particular to a method for rapidly detecting 15 prostaglandin analogs in cosmetics and application thereof. Background Art
[0002] Prostaglandin analogues (PGA) are derivatives or structural analogs of endogenous prostaglandins. Some compounds have the effect of reducing intraocular pressure and are often used clinically to treat glaucoma, ocular hypertension, etc. Clinical medication has found that prostaglandin analogues can increase hair length, lengthen the hair growth cycle, slow down the rate of hair loss, and make the hair appear thicker. Previously, the 0.03% bimatoprost ophthalmic solution developed by Allergan was approved by the FDA and included in the drug management for the treatment of hypolashes. Some cosmetics merchants take advantage of this pharmacological characteristic of prostaglandin analogues and arbitrarily add prostaglandin analogues to eyelash cosmetics, causing adverse reactions such as pigmentation, eye swelling and itching, and even causing serious adverse consequences such as vision loss and blindness. Not only that, the use of pregnant and lactating women may have adverse effects on the fetus and infants, and the FDA pregnancy rating is C.
[0003] At present, the detection of prostaglandin analogues reported in the literature mostly includes fluorescence spectrophotometry, high performance liquid chromatography and high performance liquid chromatography-tandem triple quadrupole mass spectrometry. The State Food and Drug Administration has issued the Supplementary Inspection Method for Cosmetics (BJH 202102) "Determination of 5 Components Including Bimatoprost in Cosmetics". This method uses high performance liquid chromatography-tandem triple quadrupole mass spectrometry to detect bimatoprost, tafluoroacetamide, latanoprost, travoprost and tafluprost. However, high performance liquid chromatography and high performance liquid chromatography-tandem triple quadrupole mass spectrometry are only applicable to the analysis of known compounds, and it is difficult to perform rapid screening in the absence of standards. Considering that ultra-high performance liquid chromatography technology has the advantages of fast analysis speed, high separation efficiency, high sample throughput and high sensitivity compared to traditional high performance liquid chromatography, quadrupole-time of flight mass spectrometry, as a type of high-end tandem mass spectrometry technology, has higher accuracy in the qualitative identification of compounds. In addition, Wang Xinran, Yin Weicheng and others have established a high-resolution mass spectrometry method for screening 9 prostaglandins in cosmetics, including common bimatoprost and travoprost, but the number is small and the coverage is incomplete. In summary, in response to the above-mentioned problems existing in the existing technology, this study uses ultra-high performance liquid chromatography-quadrupole-time of flight high-resolution mass spectrometry (UPLC-Q-TOF MS) as a detection method, targeting 15 prostaglandin analogs that are widely used and easy to obtain on the market and have hair growth effects (completely covering the five components in the supplementary test method BJH 202102), in order to establish a method for rapid screening and determination of 15 prostaglandin analogs in cosmetics by ultra-high performance liquid chromatography-quadrupole-time of flight high-resolution mass spectrometry, so as to provide more comprehensive and effective technical support for cosmetics quality supervision. Summary of the invention
[0004] The purpose of the present invention is to provide a method for rapidly detecting 15 prostaglandin analogs in cosmetics, which is simple, rapid and accurate.
[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0006] The present invention provides a method for rapidly detecting 15 prostaglandin analogs in cosmetics, comprising the following steps:
[0007] (1) Prepare standard solution;
[0008] (2) sample processing to obtain a sample solution to be tested;
[0009] (3) detecting the standard solution and the sample solution by ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry to establish a database;
[0010] The 15 prostaglandin analogs are: latanolide benzoate, prostaglandin e, misoprostol
[0011] travoprost, bimatoprost, (-)phenylbenzoylcorinol, bimatoprost isopropyl ester, latanoprost, tafluprost, tafluacetamide, cloprostenol, carboprost trometamol, alprostadil, carboprost methyl ester, iloprost.
[0012] Preferably, the preparation method of the standard solution is: take the 15 prostaglandin analogs, use methanol to prepare 8-12.0 μg / mL mixed standard solutions, and use 10% acetonitrile water to prepare the mixed standard solutions into a series of standard curve solutions with mass concentrations of 0.06 μg / ml, 0.1 μg / ml, 0.25 μg / ml, 0.5 μg / ml, 1 μg / ml, and 2 μg / ml, respectively.
[0013] Preferably, the sample is a cosmetic matrix in the form of an aqueous solution, cream, milk, powder or gel, and the matrix uses tetrahydrofuran as a dispersant and acetonitrile as an extraction solvent, and saturated sodium chloride is added for salting out to obtain a sample solution to be tested.
[0014] Preferably, the chromatographic conditions of the ultra-high performance liquid chromatography-quadrupole-time of flight high-resolution mass spectrometry in step (3) are as follows: Chromatographic column: Agilent Infinity Lab Poroshell 120EC-C18150mm×3.0mm, 2.7μm; mobile phase A: 0.1~5mmol / L ammonium formate containing 0.1% formic acid by mass fraction; mobile phase B: acetonitrile; flow rate: 0.4mL / min; column temperature: 38~42℃; injection volume 2.5~3.5μl; gradient elution program: 0~1.5min, 15%B; 1.5~5.5min, 15%~60%B; 5.5~13min, 60%~98%B; 13~17min, 98%B; 17~17.1min, 98%~15%B; 17.1~24min, 15%B; 22~22.1min, 98%~2%B; 22.1~25min, 2%B.
[0015] Preferably, the mass spectrometry conditions of the ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry are: ion source: ESI source; acquisition mode: positive mode scanning; nebulizer gas pressure 38-42psi; drying gas temperature 310-330°C, drying gas flow rate 9-11L / min, capillary outlet voltage 130-140V; acquisition mode is MS Scan and Targeted MS / MS: primary mass spectrometry scanning range m / z 110-1000; secondary mass spectrometry scanning range m / z 50-500; collision cell adopts collision induced dissociation mode, and collision energy is 10-40eV; reference ions: 121.0509, 922.0098m / z.
[0016] Preferably, the steps of establishing the database are as follows: first, a mixed standard solution of 8 to 12.0 μg / mL is tested according to the chromatographic and mass spectrometric conditions; in the primary full scan mode, the parent ion information of the compound is collected to determine the adduct form and the quasi-molecular ion; in the target secondary mode, different collision energies are applied, and fragment ions are collected to obtain the secondary mass spectrum of the compound;
[0017] Secondly, a primary database and a secondary standard spectral library were established. The names, molecular formulas, CAS numbers, and retention times of 15 prostaglandin analogs were input into the PCDL software to establish a compound database. The collected secondary mass spectra were used through the molecular formula search function in MassHunter to extract the primary and secondary mass spectra of the compounds and generate molecular formulas. The mass spectra were sent to the PCDL software with the theoretical mass-to-charge ratio after generating the molecular formula to establish an unbiased high-resolution screening secondary standard spectral library for the corresponding compounds.
[0018] The present invention also provides an application of the method in quantitatively detecting 15 prostaglandin analogs in cosmetics.
[0019] The present invention provides a method for rapidly detecting 15 kinds of prostaglandin analogs in cosmetics. For the 15 kinds of prostaglandin analogs that are widely used on the market, easily available, and all have hair growth effects, a method for rapidly screening and determining the 15 kinds of prostaglandin analogs in cosmetics by ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry is established. The method is simple, rapid, and accurate, and provides more comprehensive and effective technical support for cosmetics quality supervision. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 is the extracted ion map of bimatoprost in the positive sample of Experimental Example 1;
[0021] Figure 2 This is the primary mass spectrum of bimatoprost in the positive sample of Experimental Example 1;
[0022] Figure 3 The secondary spectrum of the bimatoprost positive sample in Experimental Example 1 (A), the secondary mass spectrum of the standard (B) and the mirror image comparison (C);
[0023] Figure 4 The ion flow chromatograms of 15 substances obtained in Comparative Example 1 using 0.1% formic acid (v / v)-5mmol / L ammonium formate and acetonitrile as mobile phases;
[0024] Figure 5 The extraction efficiency results of different combinations of extractants and dispersants in Comparative Example 2 are shown. DETAILED DESCRIPTION
[0025] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0026] Example 1
[0027] 1.1 Instruments and reagents
[0028] 1200 liquid chromatograph / -6538 time-of-flight mass spectrometer (Agilent, USA); XSE205DC electronic balance (Mettler); ULPHW-IV ultrapure water meter (Sichuan U-Pure Technology Co., Ltd.); MS3 vortex mixer (IKA, Germany); S120H ultrasonic instrument (Elma, Germany); ST16R high-speed refrigerated desktop centrifuge (Thermo Fisher Scientific, USA).
[0029] Standards: latanolide benzoate (purity 98%), prostaglandin e (dinoprostone) (purity 97.1%), misoprostol (purity 1%), travoprost (purity 99.9%), all purchased from Shanghai Yuanye Biotechnology Co., Ltd.; bimatoprost (purity 99.9%), (-) phenylbenzoylcoline lactone (purity 100%), bimatoprost isopropyl ester (purity 99.5%), latanoprost (purity 99.5%), tafluprost (purity 96.6%), tafluacetamide (purity 94.9%), all purchased from Cato Research Chemicals Co., Ltd. Inc; cloprostenol (purity 98.9%), carboprost trometamol (purity 97%), all purchased from Aimejie Toronto Research Chemicals; alprostadil (purity 99.0%), carboprost methyl ester (purity 99.3%), all purchased from the China National Institute for Inspection and Quarantine; iloprost (purity 98%, LGC British Government Chemical Laboratory). Acetonitrile, methanol (chromatographic grade, Merk, Germany); formic acid, ammonium formate (chromatographic grade, Sigma, Germany). Samples were from commercial eyelash cosmetics.
[0030] 1.2 Preparation of standard solution Take appropriate amount of the above standard products (15 prostaglandin analogs), accurately weigh them, and prepare mixed standard solutions of 10.0 μg / mL with methanol. Take appropriate amount of the above mixed standard solution, and prepare a series of standard curve solutions with mass concentrations of 0.06 μg / ml, 0.12 μg / ml, 0.25 μg / ml, 0.5 μg / ml, 1 μg / ml, and 2 μg / ml with 10% acetonitrile water.
[0031] 1.3 Sample treatment The sample comes from an eyelash cosmetic matrix in the form of an aqueous solution, cream, milk, powder or gel. The matrix uses tetrahydrofuran as a dispersant and acetonitrile as an extraction solvent. At the same time, saturated sodium chloride is added for salting out to obtain a sample solution to be tested. The specific steps are: take 0.1g of sample, accurately weigh it, put it in a 10mL centrifuge tube, vortex disperse it with 1mL of tetrahydrofuran, add 4mL of acetonitrile, vortex for 2min, then add 1mL of saturated sodium chloride, shake and mix, make up to 10mL with acetonitrile, vortex for 1min, centrifuge at 5000rpm for 15min, accurately pipette 1mL of supernatant into a 10ml colorimetric tube, add water to make up to 5mL scale, shake well, filter through a 0.22μm filter membrane to obtain a sample solution to be tested.
[0032] 1.4 Instrument conditions
[0033] 1.4.1 Chromatographic conditions Chromatographic column: Agilent InfinityLab Poroshell 120EC-C18 (150 mm × 3.0 mm, 2.7 μm); mobile phase A: 5 mmol / L ammonium formate (containing 0.1% formic acid by mass); mobile phase B: acetonitrile; gradient elution. Flow rate: 0.4 mL / min; column temperature: 40 °C; injection volume 3 μl. Gradient elution program: 0-1.5 min, 15% B; 1.5-5.5 min, 15%-60% B; 5.5-13 min, 60%-98% B; 13-17 min, 98% B; 17-17.1 min, 98%-15% B; 17.1-24 min, 15% B; 22-22.1 min, 98%-2% B; 22.1-25 min, 2% B.
[0034] 1.4.2 Mass spectrometry conditions Ion source: ESI source; Acquisition mode: positive mode scanning; Nebulizer gas pressure 40 psi; Drying gas temperature 320 °C, Drying gas flow rate 10 L / min; Acquisition mode is MS Scan and Targeted MS / MS: Primary mass spectrometry scanning range m / z 110~1000; Secondary mass spectrometry scanning range m / z 50~500; Collision cell adopts collision induced dissociation mode (CID), collision energy 10, 20, 40 eV; Reference ions: 121.0509, 922.0098 m / z.
[0035] 1.5 Database establishment
[0036] 1.5.1 Mass spectrometry information acquisition A 10.0 μg / mL mixed standard solution was tested according to the above-mentioned liquid chromatography and mass spectrometry conditions. In the primary full scan mode (MS Scan), the compound parent ion information was collected to determine the adduct form and quasi-molecular ion; in the targeted secondary mode (TargetedMS / MS), different fragmentation energies (10, 20, 40 eV) were applied, and fragment ions were collected to obtain the secondary mass spectrum of the compound.
[0037] 1.5.2 Establishment of primary database (Database) and secondary standard library (Library) Input the names, molecular formulas, CAS numbers, and retention times of 15 prostaglandin analogs in the mixed standard solution into the PCDL software to establish a compound database; use the molecular formula search (Find by Formula) function in MassHunter to extract the primary and secondary mass spectra of the compounds and generate molecular formulas, and send the mass spectra to the PCDL software with the theoretical mass-to-charge ratio after generating the molecular formula to establish a secondary standard library for unbiased high-resolution screening of the corresponding compounds. The mass spectrometry parameters of the 15 prostaglandin analogs are shown in Table 1.
[0038] Table 1 Mass spectrometry parameters of 15 prostaglandin analogs
[0039]
[0040]
[0041] After the experimental samples are processed, they are measured on the machine, and the collected data are imported into the PCDL software to compare the sample mass spectrum information with the compound standard library. Under the same experimental conditions, if the mass spectrum of the sample to be tested shows the same mass spectrum information as the standard in the mass spectrum of the corresponding molecular ion extracted, it can be judged that the corresponding compound exists in the sample to be tested.
[0042] 1.6 Linear range, detection limit and quantification limit
[0043] Mixed standard solutions with concentrations of 0.06μg / mL, 0.12μg / mL, 0.25μg / mL, 0.5μg / mL, 1.0μg / mL, and 2.0μg / mL were accurately measured and injected, and standard curves were drawn. The target compounds showed good linear relationships in the range of 0.06 to 2μg / mL, and the correlation coefficients of the 15 components were between 0.992 and 0.999.
[0044] The detection limit was determined by 3 times the signal-to-noise ratio (S / N=3), and the quantification limit was determined by 10 times the signal-to-noise ratio (S / N=10), and the detection limit and quantification limit of each component were obtained. The detection limit of each component was between 0.07 and 2.14 μg / g, and the quantification limit was between 0.23 and 7.14 μg / g. See Table 2 for details.
[0045] Table 2 Linear regression equation, correlation coefficient, detection limit and quantification limit of 15 compounds
[0046]
[0047]
[0048] 1.7 Recovery test
[0049] Blank matrix samples of aqueous solution, cream, milk, powder and gel were taken respectively, and after being processed according to 1.3, a certain volume of 10.0 μg / mL mixed standard solution was added respectively, and processed according to the preparation method of sample solution in Example 1 to prepare recovery solutions of low, medium and high concentration levels, and the spiked recovery and precision (n=6) were tested. The results are shown in Table 3. The average recovery of the target component was between 74.1% and 131.3%, and the relative standard deviation was less than 9.6%.
[0050] Table 3 Recovery and precision of 15 compounds (n=6)
[0051]
[0052]
[0053]
[0054]
[0055] Experimental Example 1
[0056] 65 batches of different eyelash cosmetics on the market were tested, and bimatoprost was detected in two batches of eyelash growth liquid. In the positive samples, the retention time, primary accurate mass number, and isotope abundance information of the compound can be well matched with the self-built spectral library. The extracted ion chromatogram, primary mass spectrum and matching status are shown in Figure 1-2 The determination error was -0.02ppm and the primary matching score was 96.8. The secondary spectra of the compounds in the positive samples were collected in the Targeted MS / MS mode and compared with the self-built standard library. The fragment details matched well, and the secondary matching score was 88.5 at 20eV energy. The comparison results of the secondary spectra of the compounds with the bimatoprost standard are shown in Figure 3 The positive sample bimatoprost was quantified by primary mode, and the bimatoprost contents in the two batches of samples were 330μg / g and 280μg / g, respectively.
[0057] Comparative Example 1
[0058] 0.2% and 0.5% formic acid (v / v) and 10mmol / L and 20mmol / L ammonium formate combinations were set as phase A to investigate their effects on compound response. The remaining detection steps were the same as in Example 1. The results are shown in FIG. Figure 4 As shown, it shows that the overall response of each compound is the best when 0.1% formic acid (v / v)-5mmol / L ammonium formate is used. Figure 4 In the figure, peaks 1 to 14 are: 1. (-)-corinolide benzoate; 2. bimatoprost; 3. cloprostenol; 4. prostaglandin E2; 5. alprostadil; 6. carboprost tromethamine; 7. (-)-corinolide 4-phenylbenzoate; 8. iloprost; 9. carboprost methylation; 10. bimatoprost isopropyl ester; 11. misoprostol; 12. latanoprost; 13. travoprost; 14. tafluprost; 15. tafluprost acetamide.
[0059] Comparative Example 2
[0060] Using saturated sodium chloride as a dispersant and acetonitrile as an extraction solvent cannot completely dissolve insoluble matrices such as pastes; using tetrahydrofuran as a dispersant and acetonitrile as an extraction solvent, and adding saturated sodium chloride for salting out. In addition, prostaglandin compounds have long carbon chains and ester bonds, and ethyl acetate is introduced as an extraction agent to compare the recovery rate in parallel. The extraction results are shown in Figure 5 , indicating that tetrahydrofuran-acetonitrile-saturated sodium chloride had the highest extraction efficiency, and this combination was finally used as the extraction solvent.
[0061] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A method for rapid detection of 15 prostaglandin analogs in cosmetics. It is characterized in that The steps include: (1) Prepare standard solution; (2) sample processing to obtain a sample solution to be tested; (3) detecting the standard solution and the sample solution by ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry to establish a database; The 15 prostaglandin analogs are: latanoprost benzoate, prostaglandin E, misoprostol, travoprost, bimatoprost, (-)phenylbenzoylcoline lactone, bimatoprost isopropyl, latanoprost, tafluprost, tafluacetamide, cloprostenol, carboprost tromethamine, alprostadil, carboprost methyl ester and iloprost.
2. The method according to claim 1, It is characterized in that The preparation method of the standard solution is: take the 15 prostaglandin analogs, use methanol to prepare mixed standard solutions of 8-12.0 μg / mL respectively, and use 10% acetonitrile water to prepare the mixed standard solutions into a series of standard curve solutions with mass concentrations of 0.06 μg / ml, 0.1 μg / ml, 0.25 μg / ml, 0.5 μg / ml, 1 μg / ml, and 2 μg / ml respectively.
3. The method according to claim 2, It is characterized in that The sample is a cosmetic base in the form of an aqueous solution, cream, milk, powder or gel. The cosmetic base uses tetrahydrofuran as a dispersant and acetonitrile as an extraction solvent. Saturated sodium chloride is added for salting out to obtain a sample solution to be tested.
4. The method according to claim 3, It is characterized in that The chromatographic conditions of the ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry in step (3) are as follows: chromatographic column: Agilent Infinity Lab Poroshell 120EC-C18, 150 mm×3.0 mm, 2.7 μm; mobile phase A: 0.1-5 mmol / L ammonium formate containing 0.1% formic acid by mass; mobile phase B: acetonitrile; flow rate: 0.4 mL / min; column temperature: 38-42° C.; injection volume: 2.5-3.5 μl; gradient elution program: 0-1.5 min, 15% B; 1.5-5.5 min, 15%-60% B; 5.5~13min, 60%~98%B; 13~17min, 98%B; 17~17.1min, 98%~15%B; 17.1~24min, 15%B; 22~22.1min, 98%~2%B; 22.1~25min, 2%B.
5. The method according to claim 4, It is characterized in that The mass spectrometry conditions of the ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry are as follows: ion source: ESI source; acquisition mode: positive mode scanning; nebulizer gas pressure 38-42 psi; drying gas temperature 310-330° C., drying gas flow rate 9-11 L / min, capillary outlet voltage 130-140 V; acquisition mode is MSScan and Targeted MS / MS: primary mass spectrometry scanning range m / z 110-1000; secondary mass spectrometry scanning range m / z 50-500; collision cell adopts collision induced dissociation mode, and collision energy is 10-40 eV; reference ions: 121.0509, 922.0098 m / z.
6. The method according to claim 1, It is characterized in that The steps of establishing the database are as follows: first, a mixed standard solution of 8 to 12.0 μg / mL is tested according to the chromatographic and mass spectrometric conditions; in the primary full scan mode, the parent ion information of the compound is collected to determine the adduct form and the quasi-molecular ion; in the target secondary mode, different collision energies are applied and fragment ions are collected to obtain the secondary mass spectrum of the compound; Secondly, a primary database and a secondary standard spectral library were established. The names, molecular formulas, CAS numbers, and retention times of 15 prostaglandin analogs were input into the PCDL software to establish a compound database. The collected secondary mass spectra were used through the molecular formula search function in MassHunter to extract the primary and secondary mass spectra of the compounds and generate molecular formulas. The mass spectra were sent to the PCDL software with the theoretical mass-to-charge ratio after generating the molecular formula to establish an unbiased high-resolution screening secondary standard spectral library for the corresponding compounds.
7. Use of the method according to any one of claims 1 to 6 for quantitatively detecting 15 prostaglandin analogs in cosmetics.
